Acute leukemia secondary to multiple myeloma.

von de Gramont, A., Rioux, E., Shields, C.
Veröffentlicht 1983

Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer

von Louvet, C., André, T., Gamelin, E., Hebbar, M., Mabro, M., Bennamoun, M., Rassam, H., de Gramont, A.
Veröffentlicht 2010

Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma

von Santos, C D, Tijeras-Raballand, A, Serova, M, Sebbagh, S, Slimane, K, Faivre, S, de Gramont, A, Raymond, E
Veröffentlicht in Br J Cancer (2015)

Accomplishments in 2008 in the Adjuvant Treatment of Colon Cancer

von Marshall, John L., de Gramont, Aimery, Köhne, Claus-Henning, Marshall, J.L., de Gramont, A., Köhne, C.-H.
Veröffentlicht 2009

A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients

von Mabro, M, Artru, P, André, T, Flesch, M, Maindrault-Goebel, F, Landi, B, Lledo, G, Plantade, A, Louvet, C, de Gramont, A
Veröffentlicht 2006

Two or Three Year Disease Free Survival (DFS) as a Primary Endpoint in Stage III Adjuvant Colon Cancer Trials with fluoropyrimidines with or without Oxaliplatin or Irinotecan: Data...

von Sargent, D, Shi, Q, Yothers, G, Van Cutsem, E, Cassidy, J, Saltz, L, Wolmark, N, Bot, B, Grothey, A, Buyse, M, de Gramont, A
Veröffentlicht 2011

Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCEN...

von Taieb, J., Shi, Q., Pederson, L., Alberts, S., Wolmark, N., Van Cutsem, E., de Gramont, A., Kerr, R., Grothey, A., Lonardi, S., Yoshino, T., Yothers, G., Sinicrope, F.A., Zaanan, A., André, T.
Veröffentlicht in Ann Oncol (2019)

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group

von Bleiberg, H., Decoster, G., de Gramont, A., Rougier, P., Sobrero, A., Benson, A., Chibaudel, B., Douillard, J. Y., Eng, C., Fuchs, C., Fujii, M., Labianca, R., Larsen, A. K., Mitchell, E., Schmoll, H. J., Sprumont, D., Zalcberg, J.
Veröffentlicht in Ann Oncol (2017)

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population(†)

von Renfro, L. A., Grothey, A., Kerr, D., Haller, D. G., André, T., Van Cutsem, E., Saltz, L., Labianca, R., Loprinzi, C. L., Alberts, S. R., Schmoll, H., Twelves, C., Yothers, G., Sargent, D. J., Sargent, D.J., Green, E., Grothey, A., Alberts, S.R., Shi, Q., Renfro, L.A., Yothers, G., O'Connell, M.J., Wolmark, N., de Gramont, A., Gray, R., Kerr, D., Haller, D.G., Guthrie, K., Buyse, M., Labianca, R., Seitz, J.F., O'Callaghan, C.J., Francini, G., Catalano, P.J., Blanke, C.D., Andre, T., Goldberg, R.M., Benson, A., Twelves, C., Sirzen, F., Cisar, L., Van Cutsem, E., Saltz, L.
Veröffentlicht in Ann Oncol (2015)